ÂÜÀòÂÒÂ×

Kathryn Lang is a seasoned professional in the field of hematology-oncology with extensive experience in leadership roles. Currently serving as a Scientific Advisory Board Member at Karius since January 2023, Kathryn has previously held senior positions including SVP of Data & Digital at Freenome and SVP of Clinical at Paradigm. Prior roles include Vice President of Outcomes and Evidence at Guardant Health and Global Head of Oncology RWE at Pfizer. Kathryn's career in healthcare began with a focus on hematology-oncology at NHS, where service spanned from 2008 to 2016. Educational credentials include an MBBS from Newcastle University, MRCP(UK) from the Royal College of Physicians, an MRes in Epidemiological Design and Analysis from Erasmus University Rotterdam, and FRCPath in Haematology from the Royal College of Pathology.